NiKang Therapeutics, Inc.

Biotechnology company · Wilmington, Delaware, United States

NiKang Therapeutics, Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $200 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

NiKang Therapeutics at a glance

Typebiotechnology company

HeadquartersWilmington, Delaware, United States

Earliest incorporation on record2017

SEC CIK1864608

What does NiKang Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $200 million sold (2021).

Frequently asked questions about NiKang Therapeutics

Where is NiKang Therapeutics headquartered?

NiKang Therapeutics, Inc. is headquartered in Wilmington, Delaware, United States.

What does NiKang Therapeutics do?

NiKang Therapeutics, Inc. is a biotechnology company.

When was NiKang Therapeutics founded?

The earliest incorporation on record for NiKang Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
OpiAID, LLCWilmington, North Carolina, United States
Synnovation Therapeutics, Inc.Wilmington, Delaware, United States
Treadwell CorporationWilmington, North Carolina, United States
GPN Vaccines, Inc.Wilmington, Delaware, United States
Advanced Materials Technology, Inc.Wilmington, Delaware, United States
Compact Membrane Systems, Inc.Wilmington, Delaware, United States
StimuSIL, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences